Dr. David Guardamino Ojeda (MD, Postdoctoral Researcher) presented a novel method of VLDL-lipidomics to study MASLD at the 2024 DDW - Therapeutic Choice and the Pipeline for MASLD and MASH.
Dr. Guardamino Ojeda presenting at 2024 DDW
Dr. David Guardamino Ojeda (MD, Postdoctoral Researcher) presented a novel method of VLDL-lipidomics to study MASLD at the 2024 DDW - Therapeutic Choice and the Pipeline for MASLD and MASH.